Supply Chain Management
Sourcing & Contract Management
Request for Proposal
Bid Number #: CONST-00935-RFP
RFx Name: 3SCR1 Pharmacy Expansion for the Center for Advance Biomedical Imaging (CABI)
Open: Nov 9, 2020 5:00 PM
Close: Dec 15, 2020 2:00 PM
Name: Christopher Vest
The University of Texas MD Anderson Cancer Center
3SCR1 Pharmacy Expansion for the Center for Advance Biomedical Imaging (CABI) - CONST-00935-RFP
Introduction to MD Anderson
MD Anderson is known throughout the world for high-quality cancer care, research, academic programs and prevention services. Since its establishment in 1941, MD Anderson has made major contributions to improve the outlook for cancer patients everywhere.
MD Anderson was one of the first three federally designated comprehensive cancer centers by the National Cancer Act of 1971. A survey of health professionals has routinely ranked MD Anderson as one of the two premier cancer centers in the nation for the past eight years. Over 55,000 persons annually seek care at MD Anderson. The team approach to cancer care, pioneered at MD Anderson, has been strengthened by consolidating specialty clinics into multi-disciplinary care centers that allow patients to receive more ambulatory care and treatment in a single location.
MD Anderson offers one of the largest bone marrow and stem cell transplantation programs, as well as clinical trials to improve existing therapies. Teams of clinical specialists collaborate with scientists on problems of common interest and test theories that shorten the application of better treatment methods. Translational research studies are responsible for the promising field of chemoprevention, which uses synthetic vitamins to reverse pre-malignant lesions and halt the recurrence of some cancers, and for innovative gene therapy strategies being evaluated for several forms ofcancer.
With faculty and staff working in more than 30 buildings in the greater Houston area and in central Texas, MD Anderson is the largest freestanding cancer center in the world. The physical plant covers more than 11 million square feet, featuring the latest equipment and facilities to support growing needs in outpatient and inpatient care, research, prevention and education. It includes inpatient hospital facilities with 571 beds.
Construction projects include the addition of 12 floors that can accommodate more than 300 new inpatient beds in Alkek Hospital on the North Campus; two new research buildings on the South Campus that will house the Center for Advanced Biomedical Imaging Research and Center for Targeted Therapy as part of the McCombs Institute; and MD Anderson's first facility on its Mid Campus, a 25-story building to support current office space and future growth needs.
In addition to its main campus in the Texas Medical Center and two research campuses in Bastrop County, Texas, MD Anderson has developed a number of local, national and international affiliations
To view this solicitation please view the Online Bids/Proposals inside MD Anderson's Current Bids. If you cannot find Online Bids, you can copy and paste the link below inside your web browser: www.mdanderson.org/about-md-anderson/business-legal/doing-business/vendors-and-suppliers/current-bids.html PLEASE BE SURE TO CLICK "View Online Bids" Please contact Christopher Vest if you have any questions - firstname.lastname@example.org
Note: A pre-proposal conference is required. Attendance at this meeting is highly recommended for all potential Suppliers. Attendees are limited to two (2) representatives per company.
|Pre-Bid Location:||WebEx meeting|
|Date / Time:||Wednesday, November 18, 2020 10:00 AM|
|Reserve by:||Monday, November 9, 2020 1:00 PM|
|Send your Pre-Bid reservation to:||CCVest@mdanderson.org|
|Pre-Bid Comments:||Join WebEx meeting Meeting number (access code): 127 279 9463 Meeting password: qgJTyUid255|
Questions related to this RFx must be sent through the messaging board via the Ariba RFx tool. All questions must be received no later than December 1, 2020 4:00 PM. Questions received after this time will not be accepted. Questions will not be answered via telephone. All answers to any questions or inquiries will be posted on the Ariba RFx tool for all Suppliers to access. It is the intent of MD Anderson to respond to all questions and concerns; however, MD Anderson shall reserve the right to decline to respond to any question or concern.
This RFx is for review purposes only. Proposals will not be accepted if not submitted through MD Anderson's online Ariba Sourcing tool. With this process, you will be able to respond to our RFx, including specifications, terms and conditions, and other pertinent documents within one centralized web console.
Interested Suppliers Next Step
The next step in this process is for you to register your company information on Ariba Supplier Portal. To participate in this sourcing event or any future events, MD Anderson now requires ALL suppliers, regardless of current business relationship, to complete an online registration. This will allow us to collect general information about your company. Visit our website at www.mdanderson.org/suppliers, click on the Supplier Registration link and complete your company registration. It is important to keep in mind that registration through the Ariba site is the first step in doing business with MD Anderson. Additional important steps are still required from you in order to participate in this event. Please view the registration instruction carefully on how to add MD Anderson as your Buyer Company after registration is completed. Once you have successfully added us as your Buyer Company, we will review and approve your request. Once you have been approved, you will be invited to participate in this event or in any current RFx's that match to your company commodities.
***Interested suppliers should also note that Subcontracting Opportunities are
probable in connection with this solicitation. Please review the HUB Subcontracting Tip Sheet
***RFx refers to RFP, RFQ, RFI, ITB, etc.